[VIRTUAL] The impact of the presence of vitreoretinal traction and its modification on changes in central retinal thickness following the administration of a single 0.19 mg fluocinolone acetonide (FAc) implant in patients with persistent or recurrent DME

Iluvien (fluocinolone acetonide) - Alimera Sci, EyePoint Pharma

F. Koch; P. Singh; A. Chedid; N. Brui; T. Kohnen; H. Ackermann; S. Deuchler

Sep 28, 2020